Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Fynnderella1 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1396494923243851785.png) Dr. Lynn Fynn-derella🐭 [@Fynnderella1](/creator/twitter/Fynnderella1) on x 221.3K followers
Created: 2025-07-26 01:51:22 UTC

The future of medicine is in treatment for the rare occasions of infection, not injecting the masses with toxins and adjuvants in the off chance they will be exposed to said pathogen. 
When they use relative risk reduction as an efficacy endpoint because the disease is so RARE they cannot properly even study it, that tells me the risk of the masses even getting the infection is exceedingly low. All of these resources should go to treatment. JMHO.


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948924070373868028/c:line.svg)

[Post Link](https://x.com/Fynnderella1/status/1948924070373868028)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Fynnderella1 Avatar Dr. Lynn Fynn-derella🐭 @Fynnderella1 on x 221.3K followers Created: 2025-07-26 01:51:22 UTC

The future of medicine is in treatment for the rare occasions of infection, not injecting the masses with toxins and adjuvants in the off chance they will be exposed to said pathogen. When they use relative risk reduction as an efficacy endpoint because the disease is so RARE they cannot properly even study it, that tells me the risk of the masses even getting the infection is exceedingly low. All of these resources should go to treatment. JMHO.

XXXXX engagements

Engagements Line Chart

Post Link

post/tweet::1948924070373868028
/post/tweet::1948924070373868028